Marc Cobo Receives Stock Award at BridgeBio Oncology Therapeutics Inc (BBOT) — SEC Form 4, Sep 14, 2026

SEC Form 4 · No Market Transaction

Stock Award

Compensation grant — no market purchase or sale.

Reporting Owner

Marc Cobo

CAO

TXN 2026-09-10 · FILED 2026-09-14

Equity Position 14.3K sh 5,509 → 14,344

Equity Change +160.4% shares held after vs before

Filing Lag 2 business days within 2-day SEC deadline

Form 4 · Statement of Changes in Beneficial Ownership

BridgeBio Oncology Therapeutics Inc

BBOT CIK 0001869105

Reporting Owner

Name	Relationship
Marc Cobo CIK 0001816654	CAO

Marc Cobo at BridgeBio Oncology Therapeutics Inc Full insider history

Bought (12 mo) —

Sold (12 mo) —

More from this insider at BridgeBio Oncology Therapeutics Inc

Non-Derivative Securities Transactions

Title	Date	Type	Shares	Price	Net Total	Post-Txn	Ownership
Common StockF1	2026-09-10	A - Award/Grant	9,038 A	$0.00	—	14,344	Direct
Common StockF2	2026-09-10	F - Tax Payment	203 D	$5.52	-$1,121	14,141	Direct

Derivative Securities Transactions

Title	Strike	Date	Type	Shares	Price	Expiration	Underlying	Ownership
Stock Option (Right to Buy)F3	$5.52	2026-09-10	A - Award/Grant	43,700 A	$0.00	2036-09-09	43,700 Common Stock	Direct

Footnotes (3)

F1: Represents a grant of restricted stock units ("RSUs"), each representing a contingent right to receive one share of the Issuer's Common Stock. The RSUs vest in 16 equal quarterly installments over a period of four years from April 21, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date. The RSUs will be settled in shares of Common Stock upon vesting. Show more
F2: Represents the number of shares of the Issuer's Common Stock withheld by the Issuer to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of RSUs. Show more
F3: 1/48th of the shares subject to such option vest and become exercisable in substantially equal monthly installments on each monthly anniversary of April 21, 2026, subject to the Reporting Person's continuous service to the Issuer on each such date. Show more

5%+ Holders · 13D/G 7 filers

Latest Schedule 13D/G per filer; stakes the filer reported closed are left out.

Other insiders at BridgeBio Oncology Therapeutics Inc

GET /v1/forms/4/0001193125-26-390624 API docs